Obesity and Chronic Kidney Disease

Seminars in Nephrology

Volumn 29, Issue 5, 2009, Pages 504-511

  Ritz, Eberhard ^a   Koleganova, Nadezda ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

chronic kidney disease; end stage kidney disease; Obesity; visceral obesity

Indexed keywords

ARTICLE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE MODEL; EPIDEMIC; FOOD INTAKE; HUMAN; INSULIN RESISTANCE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY PARENCHYMA; LIFE EXPECTANCY; NONHUMAN; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VISCERA; WEIGHT GAIN;

HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; OBESITY;

EID: 69949127004     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2009.06.007     Document Type: Article

References (71)

1. Haslam D.W., and James W.P. Obesity. Lancet 366 (2005) 1197-1209
2. Pereira M.A., Kartashov A.I., Ebbeling C.B., Van Horn L., Slattery M.L., Jacobs Jr. D.R., et al. Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet 365 (2005) 36-42
3. Yoon K.H., Lee J.H., Kim J.W., Cho J.H., Choi Y.H., Ko S.H., et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 368 (2006) 1681-1688
4. Zimmet P., Alberti G., Kaufman F., Tajima N., Silink M., Arslanian S., et al. The metabolic syndrome in children and adolescents. Lancet 369 (2007) 2059-2061
5. Kipping R.R., Jago R., and Lawlor D.A. Obesity in children. Part 1: epidemiology, measurement, risk factors, and screening. BMJ 337 (2008) a1824
6. Olshansky S.J., Passaro D.J., Hershow R.C., Layden J., Carnes B.A., Brody J., et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352 (2005) 1138-1145
7. Mann C.C. Public health. Provocative study says obesity may reduce U.S. life expectancy. Science 307 (2005) 1716-1717
8. Hall J.E., Kuo J.J., da Silva A.A., de Paula R.B., Liu J., and Tallam L. Obesity-associated hypertension and kidney disease. Curr Opin Nephrol Hypertens 12 (2003) 195-200
9. Henegar J.R., Bigler S.A., Henegar L.K., Tyagi S.C., and Hall J.E. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 12 (2001) 1211-1217
10. Griffin K.A., Kramer H., and Bidani A.K. Adverse renal consequences of obesity. Am J Physiol Renal Physiol 294 (2008) F685-F696
11. Tomaszewski M., Charchar F.J., Maric C., McClure J., Crawford L., Grzeszczak W., et al. Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 71 (2007) 816-821
12. Krikken J.A., Lely A.T., Bakker S.J., and Navis G. The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int 71 (2007) 260-265
13. Rook M., Bosma R.J., van Son W.J., Hofker H.S., van der Heide J.J., ter Wee P.M., et al. Nephrectomy elicits impact of age and BMI on renal hemodynamics: lower postdonation reserve capacity in older or overweight kidney donors. Am J Transplant 8 (2008) 2077-2085
14. Bosma R.J., Kwakernaak A.J., van der Heide J.J., de Jong P.E., and Navis G.J. Body mass index and glomerular hyperfiltration in renal transplant recipients: cross-sectional analysis and long-term impact. Am J Transplant 7 (2007) 645-652
15. Chagnac A., Weinstein T., Herman M., Hirsh J., Gafter U., and Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 14 (2003) 1480-1486
16. Perrini S., Leonardini A., Laviola L., and Giorgino F. Biological specificity of visceral adipose tissue and therapeutic intervention. Arch Physiol Biochem 114 (2008) 277-286
17. Phillips L.K., and Prins J.B. The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 10 (2008) 156-164
18. Bays H.E., Gonzalez-Campoy J.M., Bray G.A., Kitabchi A.E., Bergman D.A., Schorr A.B., et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 6 (2008) 343-368
19. Kim J.Y., van de Wall E., Laplante M., Azzara A., Trujillo M.E., Hofmann S.M., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117 (2007) 2621-2637
20. Petersen K.F., and Shulman G.I. Etiology of insulin resistance. Am J Med 119 Suppl 1 (2006) S10-S16
21. Klein S., Fontana L., Young V.L., Coggan A.R., Kilo C., Patterson B.W., et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350 (2004) 2549-2557
22. Pinto-Sietsma S.J., Navis G., Janssen W.M., de Zeeuw D., Gans R.O., and de Jong P.E. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41 (2003) 733-741
23. Bonnet F., Marre M., Halimi J.M., Stengel B., Lange C., Laville M., et al. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR study. J Hypertens 24 (2006) 1157-1163
24. Arner P. Introduction: the inflammation orchestra in adipose tissue. J Intern Med 262 (2007) 404-407
25. Becker B., Kronenberg F., Kielstein J.T., Haller H., Morath C., Ritz E., et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 16 (2005) 1091-1098
26. Lastra G., Manrique C., and Sowers J.R. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv Chronic Kidney Dis 13 (2006) 365-373
27. Rocchini A.P., Katch V., Kveselis D., Moorehead C., Martin M., Lampman R., and Gregory M. Insulin and renal sodium retention in obese adolescents. Hypertension 14 (1989) 367-374
28. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 19 (2001) 523-528
29. Sarafidis P.A., Whaley-Connell A., Sowers J.R., and Bakris G.L. Cardiometabolic syndrome and chronic kidney disease: what is the link?. J Cardiometab Syndr 1 (2006) 58-65
30. Cassis L.A., Police S.B., Yiannikouris F., and Thatcher S.E. Local adipose tissue renin-angiotensin system. Curr Hypertens Rep 10 (2008) 93-98
31. Vogt B., Bochud M., and Burnier M. The association of aldosterone with obesity-related hypertension and the metabolic syndrome. Semin Nephrol 27 (2007) 529-537
32. Shibata S., Nagase M., Yoshida S., Kawachi H., and Fujita T. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension 49 (2007) 355-364
33. Ehrhart-Bornstein M., Lamounier-Zepter V., Schraven A., Langenbach J., Willenberg H.S., Barthel A., et al. Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci U S A 100 (2003) 14211-14216
34. Goodfriend T.L., Ball D.L., Egan B.M., Campbell W.B., and Nithipatikom K. Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension 43 (2004) 358-363
35. Verhave J.C., Hillege H.L., Burgerhof J.G., Janssen W.M., Gansevoort R.T., Navis G.J., et al. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 256 (2004) 324-330
36. Bello A.K., de Zeeuw D., El Nahas M., Brantsma A.H., Bakker S.J., de Jong P.E., et al. Impact of weight change on albuminuria in the general population. Nephrol Dial Transplant 22 (2007) 1619-1627
37. Wolf G., Chen S., Han D.C., and Ziyadeh F.N. Leptin and renal disease. Am J Kidney Dis 39 (2002) 1-11
38. Sharma K., Ramachandrarao S., Qiu G., Usui H.K., Zhu Y., Dunn S.R., et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118 (2008) 1645-1656
39. Sanchez-Lozada L.G., Tapia E., Jimenez A., Bautista P., Cristobal M., Nepomuceno T., et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 292 (2007) F423-F429
40. Elsayed E.F., Tighiouart H., Weiner D.E., Griffith J., Salem D., Levey A.S., et al. Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis 52 (2008) 49-57
41. Sanches F.M., Avesani C.M., Kamimura M.A., Lemos M.M., Axelsson J., Vasselai P., et al. Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis 52 (2008) 66-73
42. Praga M., Hernandez E., Andres A., Leon M., Ruilope L.M., and Rodicio J.L. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 70 (1995) 35-41
43. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., and Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006) 21-28
44. Wang Y., Chen X., Song Y., Caballero B., and Cheskin L.J. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 73 (2008) 19-33
45. Iseki K., Ikemiya Y., Kinjo K., Inoue T., Iseki C., and Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65 (2004) 1870-1876
46. Kurella M., Lo J.C., and Chertow G.M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16 (2005) 2134-2140
47. Foster M.C., Hwang S.J., Larson M.G., Lichtman J.H., Parikh N.I., Vasan R.S., et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 52 (2008) 39-48
48. Ryu S., Chang Y., Woo H.Y., Kim S.G., Kim D.I., Kim W.S., et al. Changes in body weight predict CKD in healthy men. J Am Soc Nephrol 19 (2008) 1798-1805
49. Young J.A., Hwang S.J., Sarnak M.J., Hoffmann U., Massaro J.M., Levy D., et al. Association of visceral and subcutaneous adiposity with kidney function. Clin J Am Soc Nephrol 3 (2008) 1786-1791
50. Iseki K., Tohyama K., Matsumoto T., and Nakamura H. High prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD). Hypertens Res 31 (2008) 249-255
51. Reeves G.K., Pirie K., Beral V., Green J., Spencer E., and Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335 (2007) 1134
52. Adams K.F., Leitzmann M.F., Albanes D., Kipnis V., Moore S.C., Schatzkin A., et al. Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol 168 (2008) 268-277
53. Renehan A.G., Tyson M., Egger M., Heller R.F., and Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371 (2008) 569-578
54. Obligado S.H., and Goldfarb D.S. The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21 (2008) 257-264
55. Nasr S.H., D'Agati V.D., Said S.M., Stokes M.B., Largoza M.V., Radhakrishnan J., et al. Oxalate nephropathy complicating Roux-en-Y gastric bypass: an underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol 3 (2008) 1676-1683
56. Weisinger J.R., Kempson R.L., Eldridge F.L., and Swenson R.S. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 81 (1974) 440-447
57. Kambham N., Markowitz G.S., Valeri A.M., Lin J., and D'Agati V.D. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59 (2001) 1498-1509
58. Chen H.M., Liu Z.H., Zeng C.H., Li S.J., Wang Q.W., and Li L.S. Podocyte lesions in patients with obesity-related glomerulopathy. Am J Kidney Dis 48 (2006) 772-779
59. Serra A., Romero R., Lopez D., Navarro M., Esteve A., Perez N., et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int 73 (2008) 947-955
60. Rea D.J., Heimbach J.K., Grande J.P., Textor S.C., Taler S.J., Prieto M., et al. Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int 70 (2006) 1636-1641
61. Altiparmak M.R., Pamuk O.N., Pamuk G.E., Apaydin S., and Ozbay G. Diffuse diabetic glomerulosclerosis in a patient with impaired glucose tolerance: report on a patient who later develops diabetes mellitus. Neth J Med 60 (2002) 260-262
62. Souraty P., Nast C.C., Mehrotra R., Barba L., Martina J., and Adler S.G. Nodular glomerulosclerosis in a patient with metabolic syndrome without diabetes. Nat Clin Pract Nephrol 4 (2008) 639-642
63. Praga M., and Morales E. Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens 15 (2006) 481-486
64. Praga M., Hernandez E., Herrero J.C., Morales E., Revilla Y., Diaz-Gonzalez R., et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 58 (2000) 2111-2118
65. Gonzalez E., Gutierrez E., Morales E., Hernandez E., Andres A., Bello I., et al. Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney. Kidney Int 68 (2005) 263-270
66. Praga M. Synergy of low nephron number and obesity: a new focus on hyperfiltration nephropathy. Nephrol Dial Transplant 20 (2005) 2594-2597
67. Morales E., Valero M.A., Leon M., Hernandez E., and Praga M. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 41 (2003) 319-327
68. Alexander M.P., Patel T.V., Farag Y.M., Florez A., Rennke H.G., and Singh A.K. Am J Kidney Dis 53 (2009) 751-759
69. Bonnet F., Deprele C., Sassolas A., Moulin P., Alamartine E., Berthezene F., et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 37 (2001) 720-727
70. Kaartinen K., Syrjanen J., Porsti I., Harmoinen A., Pasternack A., Huhtala H., et al. Insulin resistance and the progression of IgA glomerulonephritis. Nephrol Dial Transplant 22 (2007) 778-783
71. Meier-Kriesche H.U., Arndorfer J.A., and Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 73 (2002) 70-74